Hypertension and the insulin-related metabolic syndrome: Factor analysis in 17,539 Taiwanese

Acta Cardiologica Sinica

Volumn 20, Issue 4, 2004, Pages 229-236

  Chuang, Shao Yuan ^a   Chen, Chen Huan ^a,b   Chou, Pesus ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Factor analysis; Hypertension; Insulin resistance; Metabolic syndrome

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FACTORIAL ANALYSIS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PRINCIPAL COMPONENT ANALYSIS; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; STATISTICAL ANALYSIS; SYSTOLIC BLOOD PRESSURE; TAIWAN; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 13844281418     PISSN: 10116842     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Isomaa B. A major health hazard: the metabolic syndrome. Life Sci 2003;73:2395-411.
2. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607.
3. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
4. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-53.
5. Sowers JR, Frohlich ED. Insulin and insulin resistance: impact on blood pressure and cardiovascular disease. Med Clin North Am 2004;88:63-82.
6. Haffner SM. Epidemiology of hypertension and insulin resistance syndrome. J Hypertens 1997;15(suppl):S25-30.
7. Chen CH, Tsai ST, Chou P. Correlation of fasting serum C-peptide and insulin with markers of metabolic syndrome-X in a homogeneous Chinese population with normal glucose tolerance. Int J Cardiol 1999;68:179-86.
8. Chen CH, Lin KC, Tsai ST, Chou P. Different association of hypertension and insulin-related metabolic syndrome between men and women in 8437 nondiabetic Chinese. Am J Hypertens 2000;13:846-53.
9. Inoue S, Zimmet P. The Asia-Pacific perspective: redefining obesity and its treatment. Sydney: Health Communications Australia Pty. Limited, 2000.
10. Gray RS, Fabsitz RR, Cowan LD, et al. Risk factor clustering in the insulin resistance syndrome: the Strong Heart Study. Am J Epidemiol 1998;148:869-78.
11. Edwards KL, Burchfiel CM, Sharp DS, et al. Factors of the insulin resistance syndrome in nondiabetic and diabetic elderly Japanese-American men. Am J Epidemiol 1998;147:441-7.
12. Meigs JB, D'Agostino RS, Wilson PW, et al. Risk variable clustering in the insulin resistance syndrome: the Framingham Offspring Study. Diabetes 1997;46:1594-600.
13. Dowse GK, Collins VR, Alberti KGMM, et al. Insulin and blood pressure levels are not independently related in Mauritians of Asian Indian, Creole or Chinese origin. J Hypertens 1993;11: 297-307.
14. Zimmet PZ, Collins VR, Dowse GK, et al. Is hyperinsulinaemia a central characteristic of a chronic cardiovascular risk factor clustering syndrome? Mixed findings in Asian Indian, Creole and Chinese Mauritians. Diabet Med 1994;11:388-96.
15. Chien KL, Hsu HC, Su TC, et al. Components of insulin resistance syndrome in a community-based population assessed by log-linear models. J Formos Med Assoc 2001;100:587-91.
16. Shen BJ, Todaro JF, Niaura R, et al. Are metabolic risk factors one unified syndrome? Modeling the structure of the metabolic syndrome X. Am J Epidemiol 2003;157:701-11.
17. Edwards KL, Austin MA, Newman B, et al. Multivariate analysis of the insulin resistance syndrome in women. Arterioscler Thromb 1994;14:1940-5.
18. Snehalatha C, Sivasankari S, Satyavani K, et al. Insulin resistance alone does not explain the clustering of cardiovascular risk factors in southern India. Diabet Med 2000;17:152-7.
19. Anderson PJ, Critchley JA, Chan JC, et al. Factor analysis of the metabolic syndrome: obesity vs insulin resistance as the central abnormality. Int J Obes Relat Metab Disord 2001;25:1782-8.
20. Choi KM, Lee J, Kim KB, et al. Factor analysis of the metabolic syndrome among elderly Koreans: the South-west Seoul Study. Diabet Med 2003;20:99-104.
21. Lin WW, Chang FJ, Hwang JF, et al. Hemodynamic effects of hydralazine in mitral valve prolapse with regurgitation. Chung Hua I Hsueh Tsa Chih (Taipei) 1990;46:259-64.
22. Chan JC, Cheung JC, Lau EM, et al. The metabolic syndrome in Hong Kong Chinese: the interrelationships among its components analyzed by structural equation modeling. Diabetes Care 1996; 19:953-95.
23. Chen CH, Chuang JH, Kuo HS, et al. A population-based epidemiological study on cardiovascular risk factors in Kin-Chen, Kinmen. Int J Cardiol 1995;48:75-88.
24. Chuang SY, Chen CH, Tsai ST, Chou P. Clinical identification of the metabolic syndrome in Kinmen. Acta Cardiol Sin 2002;18: 16-23.
25. Montani JP, Antic V, Yang Z, Dulloo A. Pathways from obesity to hypertension: From the perspective of a vicious triangle. Int J Obes Relat Metab Disord 2002;26(Suppl 2):S28-38.
26. Haffner S, Taegtmeyer H. Epidemic obesity and the metabolic syndrome. Circulation 2003;108:1541-5.